{"filing":{"accession_number":"0001493152-26-028369","cik":"0000318306","ticker":"ABEO","company_name":"ABEONA THERAPEUTICS INC.","form":"8-K","filing_date":"2026-06-12","report_date":null,"primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/318306/000149315226028369/form8-k.htm"},"events":[{"id":10402,"run_id":9124,"accession_number":"0001493152-26-028369","anchor_item_number":null,"event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"Michael Amoroso resigned as a member of the Board of Directors of Abeona Therapeutics Inc. effective immediately on June 11, 2026, and also resigned from the Nominating and Corporate Governance Committee. This is a clear executive departure disclosed under Item 5.02, and board departures are material events affecting the registrant's governance structure and investor assessment.","company_name":"ABEONA THERAPEUTICS INC.","ticker":"ABEO","filing_date":"2026-06-12","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":6708,"accession_number":"0001493152-26-028369","item_number":null,"item_title":null,"event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"Michael Amoroso resigned as a member of the Board of Directors of Abeona Therapeutics Inc. effective immediately on June 11, 2026, and also resigned from the Nominating and Corporate Governance Committee. This is a clear executive departure disclosed under Item 5.02, and board departures are material events affecting the registrant's governance structure and investor assessment.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-13T00:19:11.236206+00:00","company_name":"ABEONA THERAPEUTICS INC.","ticker":"ABEO","filing_date":"2026-06-12"}]}